secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2026-05-26T12:07:16+00:00
Accession:  0001104659-26-066021
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine suspends ATM offering program; $43.9M raised to date
--------------------------------------------------------------------

- Notified TD Cowen of suspension and termination of March 21, 2025 prospectus supplement.
- No further ATM sales until new prospectus or registration statement is filed and effective.
- Sales Agreement with TD Cowen remains in full force and effect.
- Aggregate sales to date: 14,327,365 shares for $43.9M gross proceeds before expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/0001104659-26-066021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/tm2615565d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-066021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer